Addiction Science & Clinical Practice

Article	Citations
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review	61
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	37
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model	36
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	33
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled tr	32
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment	31
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Netwo	31
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	30
Multiple clinical risks for cannabis users during the COVID-19 pandemic	28
Racial/ethnic equity in substance use treatment research: the way forward	26
Substance use disorder bridge clinics: models, evidence, and future directions	26
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	23
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community	22
Adapting inpatient addiction medicine consult services during the COVID-19 pandemic	22
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	20
The impact of project ECHO on physician preparedness to treat opioid use disorder: a systematic review	20
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review	19
External validation of an opioid misuse machine learning classifier in hospitalized adult patients	18
What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology	18
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?	17
Integrating traditional practices and social network visualization to prevent substance use: study protocol for a randomized controlled trial among urban Native American emerging adults	17
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategie	17
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs	16
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems	15
Clinicians’ perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis	15

Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	14
“It’s way more than just writing a prescription”: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder	14
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	14
Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients	13
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study	13
Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities	13
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	12
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	12
Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?	12
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	11
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting	11
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers	11
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa	11
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	11
Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions	10
Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders	10
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa	10
Information technology and addiction science: promises and challenges	10
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown	10
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care	10
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study	10
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	9
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	9
“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories	9
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	9
Addressing complex pharmacy consultations: methods used to develop a person-centred intervention to highlight alcohol within pharmacist reviews of medications	8
Housing, opportunities, motivation and engagement (HOME) for homeless youth at-risk for opioid use disorder: study protocol for a randomized controlled trial	8
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	8
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose	8
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature	8
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study	8
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics	8
Expanding access to medications for opioid use disorder through locally-initiated implementation	8
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	8
Electronic cigarettes’ withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study	7
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-fe	7
Patient outcomes and experience of a task-shared screening and brief intervention service for problem substance use in South African emergency centres: a mixed methods study	7
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use	7
Physician blame and vulnerability: novel predictors of physician willingness to work with patients who misuse opioids	7
Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis	6
Alcohol consumption and dependence is linked to the extent that people experience need satisfaction while drinking alcohol in two Aboriginal and Torres Strait Islander communities	6
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England	6
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia	6
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study	6
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs	6
A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial	6
Optimizing internet-delivered cognitive behaviour therapy for alcohol misuse—a randomized factorial trial examining effects of a pre-treatment assessment interview and guidance	6
Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial	6
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	6
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations	5

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial	5
Should screening for risk of gambling-related harm be undertaken in health, care and support settings? A systematic review of the international evidence	5
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting	5
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	5
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans	5
An online self-directed program combining Community Reinforcement Approach and Family Training and parenting training for concerned significant others sharing a child with a person with problematic al	5
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	5
Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention	5
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems	5
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder	5
A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians	5
More than three times as many Indigenous Australian clients at risk from drinking could be supported if clinicians used AUDIT-C instead of unstructured assessments	5
Staff experiences of encountering and treating outpatients with substance use disorder in the psychiatric context: a qualitative study	5
Attitudes and training related to substance use in pediatric emergency departments	5
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic	5
The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-di	4
Music therapy, neural processing, and craving reduction: an RCT protocol for a mixed methods feasibility study in a Community Substance Misuse Treatment Service	4
A Delphi yarn: applying Indigenous knowledges to enhance the cultural utility of SMART Recovery Australia	4
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	4
Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care	4
An Ethnographic study of unhealthy alcohol use in a Danish Emergency Department	4
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	4
Lessons learned from housing first, rapid rehousing trials with youth experiencing homelessness	4
Facilitating rapid access to addiction treatment: a randomized controlled trial	4
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany	4
Case report: acute care management of severe opioid withdrawal with IV fentanyl	4
A mobile-based pregaming drinking prevention intervention for college students: study protocol for a randomized controlled trial	4
Alcohol, the overlooked drug: clinical pharmacist perspectives on addressing alcohol in primary care	4
Smoking cessation using preference-based tools: a mixed method pilot study of a novel intervention among smokers with low socioeconomic position	4
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis	4
Motivational network intervention to reduce substance use and increase supportive connections among formerly homeless emerging adults transitioning to housing: study protocol for a pilot randomized co	4
Patient and provider knowledge of and attitudes toward medical conditions and medication during pregnancy	4
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	4
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial	4
Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions	4
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder	4
A systematic review of substance use screening in outpatient behavioral health settings	4
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study	3
Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study	3
The validation and reliability of a Japanese version of the Problematic Online Gaming Questionnaire (POGQ-J)	3
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	3
Proceedings of the Addiction Health Services Research (AHSR) 2020: Virtual Conference: Part 2	3
Impact of the COVID-19 pandemic on burnout and perceived workplace quality among addiction treatment providers	3
Effects of morbidity on smoking cessation: a national smoking cessation program	3
Integrating patient perspectives in the development of a mobile health intervention to address chronic pain and heavy drinking in primary care: a qualitative study of patients in an urban, safety-net	3
Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.	3
“Sign Me Up”: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic	3
The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review	3
Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings	3
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	3
Feasibility and acceptability of incorporating social network visualizations into a culturally centered motivational network intervention to prevent substance use among urban Native American emerging	3
Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study	3
‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians	3
Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study	3
A Health Technician-delivered Brief Intervention linked to AUDIT for reduction of alcohol use in Chilean primary care: a randomized controlled trial	3
Using intervention mapping for hookah smoking cessation: a quasi-experimental evaluation	3
Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders	3
Mobile service delivery in response to the opioid epidemic in Philadelphia	3
Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities	3
Feasibility of a computer-assisted social network motivational interviewing intervention to reduce substance use and increase supportive connections among emerging adults transitioning from homelessne	3
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	3
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary	3
Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care	2
Automated Reinforcement Management System (ARMS): focused phase I provider feedback	2
Advancing a cascading train-the-trainer model of frontline HIV service providers in South Africa: protocol of an implementation trial	2
Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings	2
Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016–2018	2
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study	2
Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran	2
Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder	2
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people	2
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	2
A medical peer-delivered intervention comprising brief motivational interviewing via instant-messaging interaction to reduce drug misuse among youth in Hong Kong: A protocol for a randomised controlle	2
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations	2
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden	2
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	2
Shifts at The Helm: gratitude, re-commitment to our work, and a call for addictions disparities research	2
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study	2
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education	2
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model	2

Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs	2
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	2
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	2
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions	2
Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review	2
Screening for opioid use disorder and co-occurring depression and post-traumatic stress disorder in primary care in New Mexico	2
A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study	2
A shift in focus: Mothers’ descriptions of sharing a child with a co-parent with unhealthy alcohol use after participating in a support program	2
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action	2
Preliminary study of alcohol problem severity and response to brief intervention	2
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study	2
Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study	2
Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report	2
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	2
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	2
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries	2